Protagenic Therapeutics, Inc.\new (PTIX) Total liabilities 2014–2024
Protagenic Therapeutics, Inc.\new (PTIX) total liabilities at each fiscal year-end, per SEC filings.
$942,759FY2024 · since FY2014: $589,000 → $942,759
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $942,759 | +43.9% |
| FY2023 | $655,252 | -41.5% |
| FY2022 | $1.1M | +0.2% |
| FY2021 | $1.1M | -44.9% |
| FY2020 | $2.0M | — |
| FY2016 | $684,857 | -23.2% |
| FY2015 | $892,000 | +51.4% |
| FY2014 | $589,000 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice